Unilife, a manufacturer of drug delivery systems, is set to develop Unifill EZMix multiple-chamber ready-to-fill (prefilled) syringes.

Unifill EZMix syringes are with automatic (passive) safety features and are integrated within the glass barrel for the reconstitution and administration of lyophilized drugs and vaccines.

The syringes can also store a combination of liquid stable or lyophilized drugs along with up to 1mL of diluent for reconstitution.

The end-user advances the plunger to mix the lyophilized powder with the diluent, before swirling the device to complete reconstitution.

The Unifill EZMix syringe is available with either a fixed (staked) needle for drugs indicated for subcutaneous injections, or with attachable needles of up to 1.5 inches in length.

Unilife CEO Alan Shortall said Unifill EZMix syringes are designed to address the unmet needs of pharmaceutical and biotechnology companies active within the large market for lyophilized drugs and vaccines.

"Pharmaceutical companies recognize that convenient devices can help enhance therapy compliance, improve patient care and generate powerful brand differentiation within competitive therapeutic classes, therefore enabling them to increase market share and revenue,"Shortall said .

The company is also patenting for Unifill EZMix syringes.